Invasive Fungal Infections Clinical Trial
Official title:
Randomized and Multicenter Clinical Trial to Evaluate the Effectiveness and Efficiency of a Voriconazole Preemptive Genotyping Strategy in Patients With Risk of Aspergillosis
This is a phase IV pragmatic, multicentre, randomised, simple-blind, parallel arm, centre-stratified clinical trial. The main objective is to compare efficiency of voriconazole preemptive genotyping strategy, compared with routine practice.
Primary outcome is serum level of voriconazole on fifth day. Secondary outcome is a combined variable of therapeutic failure and adverse events, associated with voriconazole. A total of 146 patients with risk of undergoing invasive aspergillosis who potentially will receive voriconazole will be recruited, and CYP2C19 will be genotyped. If the patient receives voriconazole finally, he will be randomized (1:1 experimental/control). In the experimental arm patients receive dose according to pharmacogenetic algorithm including CYP2C19 genotype and clinical and demographic information. In the control arm patients receive dose according to clinical practice guidelines. In addition, a Spain national health system (NHS) point-of-view cost-effectiveness evaluation is going to be done. Direct costs calculation of each arm will be done. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05749380 -
Pharmacokinetics and Safety of AmBisome and DKF-5122
|
Phase 1 | |
| Not yet recruiting |
NCT02527928 -
Cost-Effectiveness of Amphotericin B
|
N/A | |
| Completed |
NCT02851680 -
Interest of ß 1-3 D Glucan Assays in Screening for the Onset of Invasive Aspergillosis in Neutropenic Patients With Acute Leukaemia.
|
N/A | |
| Completed |
NCT03572049 -
Endemic Mycoses Treatment With SUBA-itraconazole vs Itraconazole
|
Phase 2/Phase 3 | |
| Recruiting |
NCT05534529 -
Rezafungin Paediatric PK Study in Paediatric Subjects From Birth to <18 Years of Age
|
Phase 1 | |
| Completed |
NCT04024995 -
Revision of Antifungal Strategies Definitions for Invasive Fungal Infections in Hematological Malignancies
|
||
| Completed |
NCT00745992 -
Voriconazole Blood Level and Liver Metabolizing Enzyme in Taiwanese Patients
|
||
| Completed |
NCT06413056 -
Micafungin Versus Amphotercine B in Treatment of Invasive Fungal Infection
|
Phase 4 | |
| Recruiting |
NCT05130723 -
Pharmacokinetics of Fluconazole in Children (2-18 Years)
|
||
| Recruiting |
NCT04157465 -
Anti-fungal Strategies in Acute-on-Chronic Liver Failure Patients
|
N/A | |
| Completed |
NCT04122560 -
Fluconazole Pharmacokinetics, Including Bioavailability, in Obese Subjects After an Intravenous and Oral Administration
|
Phase 4 | |
| Completed |
NCT03262584 -
Evaluation of NGS for Detection and Follow-up of Fungal Pathogens in Immunocompromised Pediatric Patients
|
||
| Completed |
NCT02678598 -
A Retrospective Study Evaluating the Efficacy and Safety of Micafungin Sodium in the Treatment of Invasive Fungal Infections
|
N/A | |
| Completed |
NCT05491733 -
A Bioequivalence Study of APX001 High-load and Low-load Tablets
|
Phase 1 | |
| Not yet recruiting |
NCT06220370 -
PATH Study: People With Injecting Related Infections: Assessing Treatment Outcomes for Those Who Are Hospitalised.
|
||
| Completed |
NCT04777058 -
Pharmacokinetics of Isavuconazole in Patients in the Intensive Care Unit
|
||
| Recruiting |
NCT03583164 -
Evaluate F901318 Treatment of Invasive Fungal Infections in Patients Lacking Treatment Options
|
Phase 2 | |
| Completed |
NCT03174457 -
Non-interventional Study for Prevention and Treatment of Fungal Infections in Paediatric Patients in Asia/Oceania - ERADICATE Study
|
||
| Completed |
NCT00750737 -
Oral Posaconazole Three Times Per Day vs Weekly High Dose Amphotericin B Lipid Complex (ABLC)
|
Phase 3 | |
| Not yet recruiting |
NCT06346951 -
Survey on the Current Status of IFD Diagnosis and Treatment by Intensive Care Physicians in Sichuan Province (IFS)
|